Credit Suisse’s Teladoc Health TDOC Stock Holding History

Credit Suisse’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-442,000	Closed	-$40.6M	–	4289
2021 Q4	$40.6M	Buy	442,000 +85,000	+24%	+$10.2M	0.02%	739
2021 Q3	$45.3M	Sell	357,000 -602,400	-63%	-$87.7M	0.02%	681
2021 Q2	$164M	Buy	959,400 +252,400	+36%	+$40.9M	0.09%	228
2021 Q1	$128M	Buy	707,000 +192,400	+37%	+$44.6M	0.07%	322
2020 Q4	$103M	Buy	514,600 +252,200	+96%	+$51.3M	0.05%	406
2020 Q3	$57.5M	Buy	+262,400	New	+$55.6M	0.04%	554
2019 Q3	–	Sell	-30,000	Closed	-$1.99M	–	4248
2019 Q2	$1.99M	Buy	+30,000	New	+$1.75M	﹤0.01%	2452

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse's TDOC Position: Q1 2024 in Review

Credit Suisse reduced its Teladoc Health (TDOC) stake by 28% in Q1 2024, selling an estimated $6.71M and leaving 954,929 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #759.

Credit Suisse first reported a position in TDOC in Q3 2015 and has held it in 34 quarters since. The position peaked at $378M in Q2 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

Credit Suisse held 954,929 shares of Teladoc Health worth $14.4M as of Q1 2024.
Credit Suisse sold 369,818 Teladoc Health shares in Q1 2024, an estimated $6.71M.
Teladoc Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #759 holding.
Credit Suisse first reported a position in Teladoc Health in Q3 2015 and has held it in 34 quarters since.
Credit Suisse's Teladoc Health position peaked at $378M in Q2 2021.
426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.